Institute
of
Oncology
Research
Tools
Directory
www.usi.ch
Info Desk
IOR
An institute
affiliated to USI
The Institute
Research
Groups
Groups
Education
News and events
News and events
About
About
Staff
Staff
Foundation
Foundation
Facilities
Facilities
Open positions
Open positions
Support us
Support us
Partners & Supporters
Partners & Supporters
Contact
Contact
Bioinformatics Core Unit
Genomics Facility
Overview
Overview
Research Programs
Annual Reports
Annual Reports
Publications
Publications
Lymphoma and Genomics
Lymphoma and Genomics
Tumor Biology and Experimental Therapeutics
Tumor Biology and Experimental Therapeutics
Overview
Overview
Cancer Immunotherapy (Calcinotto)
Cancer Immunotherapy (Calcinotto)
Experimental Hematology (Rossi)
Experimental Hematology (Rossi)
Experimental Therapeutics (Catapano)
Experimental Therapeutics (Catapano)
Functional Cancer Genomics (Theurillat)
Functional Cancer Genomics (Theurillat)
Lymphoma Genomics (Bertoni)
Lymphoma Genomics (Bertoni)
Molecular Oncology (Alimonti)
Molecular Oncology (Alimonti)
Prostate Cancer Biology (Carbone)
Prostate Cancer Biology (Carbone)
Stem Cells and Cancer
Stem Cells and Cancer
Team
Education and training
Education and training
PhD Program
PhD Program
News
News
Events
Events
Events
01
July
2022
01.
July.
2022
IOR Lecture Series - Toward AI-Driven Precision Medicine
News
All the years
2022
2021
2020
2019
2018
2017
2016
IRB featured in the Swiss National Day tv special
A "molecular switch" turns on the unfavorable evolution of prostate tumors
SINERGIA Grant awarded Ticino scientists and clinicians for cellular senescence study
Siding with the immune system
Female researchers on the move
Immuno-oncology, a winning alliance
ShapingScience: a "taste" of USI research
Prestigious professorship awarded at the Institute of Oncology Research in Bellinzona
IOR study reveals how breast cancer therapy may be effective against COVID-19
New discovery at the IOR on mechanisms leading to the spread of metastases
Better poison dosages for better prostate cancer therapies
IOR study reveals anti-ageing therapy against metastases
IOR sets the stage for clinical study of new drug for the treatment of lymphomas and leukaemia
IOR takes part in innovative project for real-time Covid-19 testing device
IOR researchers suggest that androgen-deprivation treatments for prostate cancer could protect men from COVID-19
IOR paves the way for the clinical development of a therapy against prostate cancer metastasis
IOR lays the foundation for a new clinical trial against lymphomas
Pfizer Prize 2020, awards for IRB and IOR researchers in oncology and neurology
Full professorship at ETH Zurich granted to Prof. Dr. Andrea Alimonti
Movember at the Institute of Oncology Research
« first
‹ previous
1
2
3
4
next ›
last »
